OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1
OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations spanning diagnostics, pharmaceuticals, and innovative therapies.
Opko Health Inc. (OPK)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 47,791,243 | $63,084,441 | -2% | 0.95% |
| 2. | 9,350,000 | $12,860,402 | 3.77% | ||
| 3. | Weiss Asset Management Andrew Weiss | 4,756,992 | $6,279,229 | -58% | 0.07% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,348,166 | $4,419,581 | -32% | 0% |
| 5. | 2,000,000 | $2,748,610 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.32 | 675,000 | $891,000.00 | 214,676,448 | 2025-08-08 | Filing | |
| $1.36 | 125,000 | $169,712.50 | 214,001,448 | 2025-04-10 | Filing | |
| $1.48 | 125,000 | $184,650.00 | 213,876,448 | 2025-04-08 | Filing | |
| $1.65 | 100,000 | $164,850.00 | 213,751,448 | 2025-04-01 | Filing | |
| $1.70 | 150,000 | $254,385.00 | 213,651,448 | 2025-03-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.07 | 112,975 | $911,674.36 | 161,293 | 2017-03-14 | Filing | |
| $9.85 | 3,000 | $29,535.00 | 284,088 | 2016-05-13 | Filing | |
| $9.84 | 5,616 | $55,261.44 | 287,088 | 2016-05-13 | Filing | |
| $9.84 | 900 | $8,851.50 | 292,704 | 2016-05-13 | Filing | |
| $9.83 | 4,000 | $39,320.00 | 293,604 | 2016-05-13 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,918,000 | $9,108,357 | 0.82% | |
| 2. | 1,218,002 | $1,887,903 | 0% | |
| 3. | 690,200 | $1,030,015 | 0% | |
| 4. | 207,600 | $321,780 | 0.03% | |
| 5. | 116,681 | $180,856 | 0.05% |
News See All
12 Healthcare Stocks with Insider Buying in 2025
In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, with divergent trends in technology adoption, investment, and fundraising.
12 Best Healthcare Stocks to Buy Under $30
Mizuho health care sector strategist Jared Holz made an appearance on CNBC's "The Exchange" on July 21 to discuss the challenges facing the healthcare industry and whether there are any opportunities ...
Opko Health (OPK) Reports Fiscal Q2 2025 Results
Opko Health Inc. (NASDAQ:OPK) is one of the best strong buy penny stocks to buy now. On July 31, Opko Health Inc.
10 Best Strong Buy Penny Stocks to Buy Now
On July 28, Alan Rechtschaffen, UBS Global Wealth senior portfolio manager, appeared on CNBC’s ‘Money Movers’ to talk about the markets, his Fed outlook, and more.
OPKO Health, Inc. (NASDAQ:OPK) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the OPKO Health Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
OPKO Health (OPK) to Present Short Bowel Syndrome Treatment in Prague
OPKO Health, Inc. (NASDAQ:OPK) is one of the penny stocks that will skyrocket.
10 Penny Stocks That Will Skyrocket
Valuations in the equity markets sit at historical highs, raising questions about future market performance.
OPKO Health's (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX)
OPKO Health, Inc. (NASDAQ:OPK) is one of the Best American Penny Stocks to Buy According to Analysts. On July 8, OPKO Health, Inc. (NASDAQ:OPK) in collaboration with Entera Bio Ltd.